Skip to content

    Dare Bioscience (DARE) stock price & financials

    View DARE earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance63.4% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $41.7K
    -$63.6K
    $25.4K
    $2.3K
    -94.6%
    $152.5K
    +499.6%
    $187.5K
    Strengthening
    Operating Profit
    -$4.68M
    -$5.39M
    -$4.58M
    -$3.83M
    -$3.67M
    +21.6%
    -$1.47M
    +72.7%
    -$3.00M
    +34.5%
    -$2.97M
    +22.5%
    Strengthening
    Net Profit
    -$4.70M
    -$5.51M
    -$4.38M
    -$4.02M
    -$3.56M
    +24.2%
    -$1.44M
    +73.8%
    -$3.00M
    +31.5%
    -$2.98M
    +25.7%
    Strengthening
    EPS
    $-0.55
    $-0.50
    $-0.45
    $-0.28
    +49.1%
    $-0.21
    +58.0%
    $-0.20
    +55.6%
    Strengthening
    Other Income
    Interest
    Depreciation
    Profit before Tax
    MarginsOPM
    -11228.7%
    8465.8%
    -18016.8%
    -162340.8%
    -1345.8%
    -1967.1%
    +89.1%
    -1582.5%
    Strengthening
    Tax
    ReturnsROIC
    2.4%
    2.8%
    2.2%
    2.1%
    1.8%
    -24.2%
    0.7%
    -73.8%
    1.5%
    -31.5%
    1.5%
    -25.7%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$6.81M$4.78M$4.67M$51.67M$34.67M$10.48M$15.70M$24.71M$12.62M
    Short-Term Investments
    Total Current Assets$7.24M$6.44M$6.98M$55.30M$43.04M$17.54M$18.45M$27.06M$16.69M
    Net PP&E$9.4K$63.5K$37.9K$26.0K$522.8K$1.98M$2.54M$2.66M$2.26M
    Goodwill$0
    Intangibles
    Total Assets$7.83M$7.44M$7.55M$55.81M$43.83M$21.28M$22.10M$32.47M$22.37M
    LiabilitiesTotal Current Liabilities$1.09M$5.61M$7.66M$16.05M$31.62M$20.48M$21.61M$23.69M$16.92M
    Short-Term Debt$4.1K
    Long-Term Debt
    Long-Term Leases$389.0K$389.6K$41.8K$0$90.3K$935.7K$754.4K$559.4K$273.9K
    Total Liabilities$1.10M$7.00M$8.70M$17.05M$32.71M$26.33M$28.11M$29.63M$22.93M
    EquityCommon Stock & APIC$1.1K$2.0K$4.2K$8.4K$8.5K$833$870$1.4K$1.5K
    Retained Earnings-$28.97M-$44.02M-$71.43M-$110.13M-$141.07M-$171.24M-$175.29M-$188.69M-$194.67M
    Total Equity$6.73M$440.8K-$1.15M$38.75M$11.11M-$5.05M-$6.01M$2.84M-$560.1K
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$10.27M-$13.32M-$25.23M-$28.76M-$18.09M-$38.86M$5.47M-$9.89M-$11.29M
    Cash from Investing-$518.8K$6.14M-$17.6K-$14.5K-$63.1K-$629.4K-$573.0K-$385.3K-$461.9K
    Cash from Financing$10.11M$5.15M$25.13M$75.85M$1.34M$15.64M$354.5K$19.28M$19.31M
    SummaryCapital Expenditure-$11.8K$0-$17.6K-$14.5K-$63.1K-$629.4K-$573.0K-$385.3K-$461.9K
    Free Cash Flow-$10.28M-$13.32M-$25.25M-$28.78M-$18.15M-$39.49M$4.90M-$10.27M-$11.76M
    FCF Margin-181.5%-1406.3%50087.0%-997.0%

    Ratios